In order to delineate the respective and unique contributions of activin and TGFβ in anticipation of individual pathway inhibition in metastatic signaling, we first interrogated the association of PI3K/Akt and MEK/ERK signaling with the status of activin and TGFβ receptor expression in colon cancer patients. The gene discussed is AKT1; the disease is colonic neoplasm.